Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae067 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Abraham Tolley und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Anti-Bacterial Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Antimicrobial resistance (AMR) is a major threat to global health. By 2050, it is forecast that AMR will cause 10 million deaths and cost 100 trillion USD annually. Point-of-care tests (POCTs) may represent a cost-effective approach to reduce AMR.
Objectives
We systematically reviewed which POCTs addressing AMR have undergone economic evaluation in primary and secondary healthcare globally, how these POCTs have been economically evaluated, and which are cost-effective in reducing antimicrobial prescribing or the burden of AMR. Clinical cost-effectiveness was additionally addressed.
Methods
This systematic review, accordant with PRISMA guidelines, was pre-registered on PROSPERO (CRD42022315192). MEDLINE, PubMed, Embase, Cochrane Library, and Google Scholar were searched from 2000 to 2023 for relevant publications. Quality assessment was performed using the Consensus of Health Economic Criteria.
Results
The search strategy identified 1421 studies, of which 20 met the inclusion criteria. The most common POCTs assessed were for respiratory infections (n = 10), STIs (n = 3), and febrile patients in low- and middle-income countries (n = 3). All studies assessed costs from a healthcare provider perspective; five additionally considered the societal cost of AMR. Eighteen studies identified POCT strategies that reduced antimicrobial prescribing. Of these, 10 identified POCTs that would be considered cost-effective at a willingness-to-pay (WTP) threshold of £33.80 per antibiotic prescription avoided. Most POCT strategies improved clinical outcomes (n = 14); the remainder were clinically neutral.
Conclusions
There is evidence that some POCTs are cost-effective in reducing antimicrobial prescribing, with potential concomitant clinical benefits. Such interventions—especially CRP POCTs in both high- and low-income settings—merit further, large-scale clinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, University of Cambridge, Cambridge, UK.
- Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Department of Internal Medicine, St Vincent's Hospital, Sydney, Australia.
- Chuka County Referral Hospital, Chuka, Kenya.
ORCID-Profile: Abraham Tolley, James Howard Dicks
Zitieren
APA
Tolley, A., Bansal, A., Murerwa, R., & Howard Dicks, J. (2024). Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae067
Vancouver
Tolley A, Bansal A, Murerwa R, Howard Dicks J. Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae067
BibTeX
@article{Tolley2024,
author = {Tolley, Abraham and Bansal, Akhil and Murerwa, Rebecca and Howard Dicks, James},
title = {Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae067}
}
EUVIMED